501 related articles for article (PubMed ID: 25808906)
1. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
[TBL] [Abstract][Full Text] [Related]
2. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
Kosaraju J; Madhunapantula SV; Chinni S; Khatwal RB; Dubala A; Muthureddy Nataraj SK; Basavan D
Behav Brain Res; 2014 Jul; 267():55-65. PubMed ID: 24667360
[TBL] [Abstract][Full Text] [Related]
4. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
5. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study.
Salkovic-Petrisic M; Osmanovic-Barilar J; Brückner MK; Hoyer S; Arendt T; Riederer P
J Neural Transm (Vienna); 2011 May; 118(5):765-72. PubMed ID: 21533606
[TBL] [Abstract][Full Text] [Related]
6. Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.
Barilar JO; Knezovic A; Grünblatt E; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2015 Apr; 122(4):565-76. PubMed ID: 25503661
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.
Ravelli KG; Rosário BD; Camarini R; Hernandes MS; Britto LR
Neurotox Res; 2017 Apr; 31(3):327-333. PubMed ID: 27913964
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
[TBL] [Abstract][Full Text] [Related]
9. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
10. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578
[TBL] [Abstract][Full Text] [Related]
11. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.
Yang W; Ma J; Liu Z; Lu Y; Hu B; Yu H
Neurol Sci; 2014 May; 35(5):741-51. PubMed ID: 24337945
[TBL] [Abstract][Full Text] [Related]
12. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
[TBL] [Abstract][Full Text] [Related]
13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
14. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
[TBL] [Abstract][Full Text] [Related]
15. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia.
Bloch K; Hornfeld SH; Dar S; Vanichkin A; Gil-Ad I; Vardi P; Weizman A
PLoS One; 2020; 15(1):e0227879. PubMed ID: 31929603
[TBL] [Abstract][Full Text] [Related]
17. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).
Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171
[TBL] [Abstract][Full Text] [Related]
18. Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease.
Bloch K; Gil-Ad I; Vanichkin A; Hornfeld SH; Taler M; Dar S; Azarov D; Vardi P; Weizman A
J Alzheimers Dis; 2018; 65(4):1445-1458. PubMed ID: 30175977
[TBL] [Abstract][Full Text] [Related]
19. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
20. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
